Suppr超能文献

分娩后期单次鞘内注射舒芬太尼联合布比卡因——镇痛质量及产科结局

Single-shot intrathecal sufentanil with bupivacaine in late labour--analgesic quality and obstetric outcome.

作者信息

Eriksson Susanne Ledin, Blomberg Inger, Olofsson Christina

机构信息

Department of Anaesthesiology and Intensive Care, Gävle-Sandviken County Hospital, SE-80187, Gavle, Sweden.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2003 Oct 10;110(2):131-5. doi: 10.1016/s0301-2115(03)00049-6.

Abstract

OBJECTIVES

To investigate the analgesic effect and obstetric outcome after single-shot intrathecal sufentanil with bupivacaine in late labour.

STUDY DESIGN

Forty multiparous women in advanced labour were given a spinal injection of sufentanil 7.5 microg and bupivacaine 2 mg. Pain intensity was recorded by the parturient on a visual analogue scale. The quality of pain relief was also rated with a verbal score directly after delivery. Side effects, such as hypotension, pruritus, sedation, nausea and motor block were noted. Obstetric parameters were followed and recorded. Apgar score and umbilical artery pH were noted.

RESULTS

Median visual analogue scores after 5, 15, 30, 60, 90, 120 and 150 min were 1.5, 0.5, 0, 1, 1.5, 2 and 3, respectively. Seventy-seven percent of the parturients scored the analgesic quality as excellent. Six parturients had hypotension. Motor block, sedation and nausea were rare. Pruritus was seen in 85% of the cases. No ceasarean section was performed. Vacuum extraction was done in six (15%) cases. Oxytocin augmentation was needed in 26 (65%) of the parturients. Fetal heart rate disturbances following the spinal block were seen in four cases. Apgar scores were high. No neonate had Apgar < 7.

CONCLUSIONS

Intrathecal block with sufentanil 7.5 microg in combination with bupivacaine 2 mg is a very effective pain relief in late labour. Due to its limited duration it is important to select women in rapid progress of labour, and active obstetric management is necessary. It is also very important that the obstetrician is aware of the risk of non-reassuring fetal heart rate changes after intrathecal block.

摘要

目的

探讨分娩后期单次鞘内注射舒芬太尼联合布比卡因后的镇痛效果及产科结局。

研究设计

40例晚期分娩的经产妇接受鞘内注射7.5微克舒芬太尼和2毫克布比卡因。产妇通过视觉模拟评分法记录疼痛强度。分娩后立即用语言评分法对镇痛质量进行评估。记录低血压、瘙痒、镇静、恶心和运动阻滞等副作用。跟踪并记录产科参数。记录阿氏评分和脐动脉pH值。

结果

5、15、30、60、90、120和150分钟后的视觉模拟评分中位数分别为1.5、0.5、0、1、1.5、2和3。77%的产妇将镇痛质量评为优秀。6例产妇出现低血压。运动阻滞、镇静和恶心少见。85%的病例出现瘙痒。未进行剖宫产。6例(15%)进行了真空吸引术。26例(65%)产妇需要使用缩宫素加强宫缩。4例出现脊髓阻滞后宫内胎儿心率异常。阿氏评分较高。无新生儿阿氏评分<7分。

结论

鞘内注射7.5微克舒芬太尼联合2毫克布比卡因在分娩后期是一种非常有效的镇痛方法。由于其作用时间有限,选择产程进展快的产妇很重要,且需要积极的产科管理。产科医生意识到鞘内阻滞后胎儿心率出现异常变化的风险也非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验